Colon targeting: An emerging frontier for oral insulin delivery

Expert Opinion on Drug Delivery

Volumn 10, Issue 6, 2013, Pages 731-739

  Patel, Mayur Mahendrakumar ^a  

^a NIRMA UNIVERSITY   (India)

Author keywords

Colon targeting; Eudragit; Insulin; Particulate drug delivery; Permeation enhancers; Protease inhibitors

Indexed keywords

5 METHOXYSALICYLIC ACID; APROTININ; BACITRACIN; CAMOSTAT MESILATE; CARBOPOL934; CHITOSAN; CHITOSAN DERIVATIVE; CHOLIC ACID; DODECYL SULFATE SODIUM; EDETIC ACID; GLYCOCHOLATE SODIUM; HEXADECANOL; INSULIN; LAURATE SODIUM; OLEATE SODIUM; PENETRATION ENHANCING AGENT; POLYMER; PROTEINASE INHIBITOR; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

COLON; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; ENTERIC COATED TABLET; HUMAN; INJECTION SITE DISCOMFORT; INJECTION SITE INFECTION; INJECTION SITE IRRITATION; INJECTION SITE PAIN; INJECTION SITE REACTION; LIPOATROPHY; REVIEW;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; COLON; DRUG DELIVERY SYSTEMS; HUMANS; INSULIN;

EID: 84878050516     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.782284     Document Type: Review

References (29)

1. Available from: http://www.idf.org/diabetesatlas/5e/Update2012 [Last accessed 25 January 2013]
2. Maroni A, Zema L, Del Curto MD, et al. Oral colon delivery of insulin with the aid of functional adjuvants. Adv Drug Deliv Rev 2012;64:540-56
3. Available from: http://www.inpharmatechnologist. com/Ingredients/Drug- delivery-market-to-reach-199bn-by-2016-says-GBI-Research [Last accessed 2 January 2013]
4. Pillai O, Panchagnula R. Insulin therapies-past, present and future. Drug Discov Today 2001;6:1056-61
5. Sonia TA, Sharma CP. An overview of natural polymers for oral insulin delivery. Drug Discov Today 2012;17:784-92
6. Bernkop-Schnurch A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J Control Release 1998;52:1-16
7. Bai JPF, Chang LL, Guo JH. Effects of polyacrylic polymers on the luminal proteolysis of peptide drugs in the colon. J Pharm Sci 1995;84:1291-4
8. Aungst BJ, Saitoh H, Burcham DL, et al. Enhancement of the intestinal absorption of peptides and non-peptides. J Control Release 1996;41:19-31
9. Muranishi S. Absorption enhancers. Crit Rev Ther Drug Carrier Syst 1990;7:1-33
10. Morishita M, Peppas NA. Is the oral route possible for peptide and protein drug delivery? Drug Discov Today 2006;11:905-10
11. Patel M, Shah T, Amin A. Therapeutic opportunities in colon-specific drugdelivery systems. Crit Rev Ther Drug Carrier Syst 2007;24:147-202
12. Patel MM. Cutting-edge technologies in colon-targeted drug delivery systems. Expert Opin Drug Deliv 2011;8:1247-58
13. Patel M, Amin A. Recent trends in microbially and/or enzymatically driven colon-specific drug delivery systems. Crit Rev Ther Drug Carrier Syst 2011;28:489-552
14. Touitou E, Rubinstein A. Targeted enteral delivery of insulin to rats. Int J Pharm 1986;30:95-9
15. Gwinup G, Elias AN, Domurat ES. Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules. Gen Pharmacol 1991;22:243-6
16. Geary RS, Schlameus HW. Vancomycin and insulin used as models for oral delivery of peptides. J Control Release 1993;23:65-74
17. Torres D, Rodriguez M, Cuna M. Microencapsulated lipid cores for site-specific delivery of corticosteroid and peptide drugs to the colonic region. STP Pharm Sci 2003;13:49-56
18. Jindal SK, Singh M, Goswami M. Formulation and evaluation of insulin enteric microspheres for oral drug delivery. Acta Pharm Sci 2009;51:121-7
19. Del Curto MD, Maroni A, Palugan L, et al. Oral delivery system for two-pulse colonic release of protein drugs and protease inhibitor/absorption enhancer compounds. J Pharm Sci 2011;100:3251-9
20. Kraeling MEK, Ritschel WA. Development of a colonic release capsule dosage form and the absorption of insulin. Methods Find Exp Clin Pharmacol 1992;14:199-209
21. Ishibashi T, Hatano H, Matukawa Y, et al. Design and evaluation of a new capsule-type dosage form for colon-targeted delivery of drugs. Proc Int'l Symp Control Release Bioact Mater 1996;23:549-50
22. Saffran M, Kumar GS, Savariar C. A new approach to the oral administration of insulin and other peptide drugs. Science 1986;233:1081-4
23. Saffran M, Field JB, Pena J, et al. Oral insulin in diabetic dogs. J Endocrinol 1991;131:267-78
24. Tozaki H, Nishioka J, Komoike J, et al. Enhanced absorption of insulin and (Asu1,7)eelcalcitonin using novel azopolymer-coated pellets for colon-specific drug delivery. J Pharm Sci 2001;90:89-97
25. Rubinstein A, Radai R. In vitro and in vivo analysis of colon specificity of calcium pectinate formulations. Eur J Pharm Biopharm 1995;41:291-5
26. Cheng K, Lim LY. Insulin-loaded calcium pectinate nanoparticles: effects of pectin molecular weight and formulation pH. Drug Dev Ind Pharm 2004;30:359-67
27. Bayat A, Dorkoosh FA, Dehpour AR, et al. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies. Int J Pharm 2008;356:259-66
28. Katsuma M, Watanabe S, Kawai H, et al. Effects of absorption promoters on insulin absorption through colon-targeted delivery. Int J Pharm 2006;307:156-62
29. Tozaki H, Komoike J, Tada C, et al. Chitosan capsule for colon-specific drug delivery: improvement of insulin absorption from the rat colon. J Pharm Sci 1997;86:1016-21